Audentes Therapeutics Inc Faces Underperformance Amidst Varied Market Conditions
Audentes Therapeutics Inc, a biotechnology company specializing in gene therapy, has been experiencing a decline in share performance this week. Several factors have contributed to this underperformance, including conce...
Jul 11, 2024
• Biotechnology & Pharmaceuticals Industry
Stocks on the Move
July Pre They S South San Francisco